Politics
Pharmaceutical firms and other major donors to winning GOP candidates are ready to push their legislative agendas in Washington.
Nov. 8, 2002
Business
A federal judge has ordered Martin Shkreli to return the profits he and his company reaped from inflating the price of the life-saving drug Daraprim.
Jan. 14, 2022
Orange County Inspirational Women Forum and Leadership Awards
Dianne Whitfield, chief human resources officer at Tarsus Pharmaceuticals, brings over 20 years of HR experience to her role.
Sept. 17, 2023
Orange County Visionaries – Trends, Updates and Visionaries
Paul Edalat is a visionary leader and the chairman, founder, and CEO of Vivera Pharmaceuticals.
Oct. 15, 2023
Industry-linked groups lobby with a vengeance against bills to ease imports from the north.
May 23, 2004
Opinion
The drug industry is suing to block the government’s right to negotiate Medicare prices on 10 expensive drugs. Scores of drugs now cost over $50,000 a year.
Aug. 17, 2023
Medicine has conflict of interest policies that, while imperfect, help lessen the influence of industry in putting profits and self-interest over science and health.
Nov. 7, 2023
Jazz Pharmaceuticals’ $7.2-billion purchase of GW Pharmaceuticals last week is the biggest tie-up yet for the cannabis industry. And it’s probably just the beginning.
Feb. 7, 2021
Archives
“Health-Commerce Collision” (editorial, April 28) is right on the money, both literally and figuratively.
May 4, 2003
When drug industry pioneer Alejandro Zaffaroni looks at the world’s great pharmaceutical houses, he sees a bunch of companies that look uncannily like the Swiss watch industry just before the Japanese mass-produced time on quartz and silicon.
March 21, 1991